Advances in pharmacogenetics and pharmacogenomics related to CINV should contribute to future personalized cancer therapy strategies.

Advances in pharmacogenetics and pharmacogenomics related to CINV should contribute to future personalized cancer therapy strategies.

Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; gene therapy; diagnostic biomarkers; ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

ASHG welcomed eight 2024–2026 Human Genetics Scholars who are recognized for their accomplishments and commitment to fostering DEI in human genetics and genomics.

The Psychiatric Genomics and Pharmacogenomics Program advances scientific knowledge about genetic factors related to complex mental health conditions, especially bipolar disorder and addiction.

Background and aims: A number of case reports have documented the occurrence of acute hepatic and renal toxicity during treatment with deferasirox (DFX). The precise mechanisms underlying these ...

Emerging research in the field of pharmacoepigenetics is shedding light on how epigenetic modifications (such as DNA methylation, microRNAs, and histone acetylation) play a crucial role in regulating ...